Author： Alcorn Nicola Saunders Sarah Madhok Rajan
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.32, Iss.12, 2009-12, pp. : 1123-1134
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Benefit-Risk Assessment of Infliximab in the Treatment of Rheumatoid Arthritis
By Mikuls T.R.
Drug Safety, Vol. 26, Iss. 1, 2003-01 ,pp. :
Access to resources
Recommend
Safety evaluation of leflunomide in rheumatoid arthritis
By I Keen Helen
Expert Opinion on Drug Safety, Vol. 12, Iss. 4, 2013-07 ,pp. :
Leflunomide in Combination Therapy for Rheumatoid Arthritis
Drug Safety, Vol. 33, Iss. 6, 2010-06 ,pp. :